A 56-year-old man with a history of rheumatoid arthritis presented with a 2-day history of worsening pain in his left foot. Treatment with high-dose steroids was of no benefit, hence a diagnosis of septic arthritis was considered. However, the patient’s condition deteriorated despite empirical antibiotic therapy. Following persistent investigation, the cause was identified as a fastidious Legionella longbeachae infection, and appropriate antibiotic therapy led to complete resolution of the sepsis. This emphasises the importance of considering infections with atypical organisms in patients on immunosuppressive therapy.
In July 2008, a 56-year-old retired man presented with a 2-day history of worsening pain in his left foot. His medical history included seropositive active rheumatoid arthritis (RA), type 2 diabetes mellitus with microvascular complications, and idiopathic dilated cardiomyopathy managed with an implantable cardioverter-defibrillator and permanent pacemaker (left ventricular ejection fraction: 12% in 2006, 42% in 2008). His RA had been difficult to control — intermittent flares, usually involving his feet, were managed with high-dose steroids. Before presentation, the patient was taking weekly oral methotrexate (20 mg) and daily prednisolone (7.5 mg). Leflunomide, hydroxychloroquine and sulfasalazine therapy had failed to control his RA in the past and were withdrawn because of adverse reactions. Treatment with rituximab, an anti-CD20 monoclonal antibody, in September 2007 (two 1000 mg infusions, administered 2 weeks apart) had also failed to control his RA, and tumour necrosis factor-α (TNF-α) inhibitors were contraindicated owing to his cardiac disease.1
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Danila MI, Patkar NM, Curtis JR, et al. Biologics and heart failure in rheumatoid arthritis: are we any wiser? Curr Opin Rheumatol 2008; 20: 327-333.
- 2. Linscott AJ, Poulter MD, Ward K, Bruckner DA. Legionella pneumophila serogroup 4 isolated from joint tissue. J Clin Microbiol 2004; 42: 1365-1366.
- 3. Bemer P, Leautez S, Ninin E, et al. Legionella pneumophila arthritis: use of medium specific for mycobacteria for isolation of L. pneumophila in culture of articular fluid specimens. Clin Infect Dis 2002; 35: E6-E7.
- 4. Yu VL, Plouffe JF, Pastoris MC, et al. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. J Infect Dis 2002; 186: 127-128.
- 5. Montanaro-Punzengruber JC, Hicks L, Meyer W, Gilbert GL. Australian isolates of Legionella longbeachae are not a clonal population. J Clin Microbiol 1999; 37: 3249-3254.
- 6. Doran MF, Crowson CS, Pond GR, et al. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002; 46: 2287-2293.
None identified.